Stocks
BridgeBio Pharma, Inc.BBIO
NASDAQHealthcareBiotechnology$69.41+2.10%
Focused on genetic diseases and cancers, this biopharmaceutical firm develops therapies targeting Mendelian disorders. Investors track BridgeBio for its pipeline of precision medicines and partnerships with larger pharma companies.
Market Cap: $13.5B52W Range: $28.32 – $84.94
Congressional Interest in BridgeBio Pharma, Inc. (BBIO)
2 members of Congress have disclosed 6 trades in BridgeBio Pharma, Inc. (BBIO), a Healthcare company. The buy/sell breakdown shows 6 purchases versus 0 sales, indicating net buying interest from lawmakers. All data is sourced from STOCK Act periodic transaction reports filed with Congress.
Total Disclosures
6
Unique Politicians
2
Buys
6
Sells
0
Who in Congress Is Trading BBIO?
| Date | Politician | Type | Amount |
|---|---|---|---|
| 2026-03-19 | Gilbert Cisneros | buy | $1K – $15K |
| 2026-03-18 | Gilbert Cisneros | buy | $1K – $15K |
| 2026-03-03 | Gilbert Cisneros | buy | $1K – $15K |
| 2025-09-22 | Gilbert Cisneros | buy | $1K – $15K |
| 2025-08-08 | Gilbert Cisneros | buy | $1K – $15K |
| 2018-10-23 | JOHN K. DELANEY | buy | $15K – $50K |